News & Perspective

Sep 28, 2007

Sep 28, 2007

FDA approves sixth flu vaccine for US market

(CIDRAP News) – The Food and Drug Administration (FDA) today announced the approval of an Australian-made influenza vaccine called Afluria for use in adults, raising the number of US-licensed flu vaccines to six.

The vaccine, made by CSL Limited, based in Parkville, Australia, was approved for protecting people aged 18 and older from type A and B influenza viruses.

Aug 07, 2007

Aug 07, 2007

WHO: Indonesia's withholding of viruses endangers world

(CIDRAP News) – A World Health Organization official said yesterday that Indonesia is endangering the world's health by continuing to withhold H5N1 influenza virus samples collected from human patients.

Jul 25, 2007

Jul 25, 2007

Researchers warn H5N1 reassortment can occur beyond winter months

(CIDRAP News) – World health experts have been working under a general assumption that a feared reassortment between human and avian influenza viruses—a scenario that could spark a pandemic—might only occur during a short winter interval, but researchers who recently examined virus circulation patterns warn that time frames for coinfection are wider and sometimes unpredictable.

May 16, 2007

May 16, 2007

Syndromic surveillance: faulty alarm system or useful tool?

(CIDRAP News) – At first glance, the Web page looks like an overhead shot of a fantastic game board: a map—identifiably Los Angeles—sprinkled with faceted roundels in a half-dozen colors.

May 11, 2007

May 11, 2007

Edmonton adds ginseng product to pandemic stockpile

(CIDRAP News) – The city of Edmonton, Alta., recently announced that it was stockpiling an herbal supplement in the hope of boosting the immunity of police, firefighters, and other essential workers during an influenza pandemic.

By buying a ginseng product from CV Technologies, Inc., a company based in Edmonton, the city has become the first in North America to add an herbal supplement to its pandemic stockpile, according to media reports.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Apr 05, 2007

Apr 05, 2007

Firm seeks US license for seasonal flu vaccine

(CIDRAP News) – CSL Biotherapies, the US branch of an Australian vaccine producer, announced this week it has applied for Food and Drug Administration (FDA) approval to market a seasonal influenza vaccine in the United States.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»